Figure 1 (Ler00 0001 01)
Lerochol Injection, Solution
Product Images NDC 84685-300
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 25 technical images submitted to the FDA as part of the official labeling for Lerochol (NDC 84685-300). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Lib Therapeutics, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 2 (Ler00 0001 02)
Figure (Ler00 0001 03)
Figure A (Ler00 0001 04)
This text appears to be detailing the steps or components involved in using a syringe. It mentions a plunger rod, medicine, syringe label with expiration dates, a needle cap, and a needle. It seems to be providing information on what to do before and after using a syringe.*
Figure B (Ler00 0001 05)
This is not readable.*
Figure C (Ler00 0001 06)
Figure D (Ler00 0001 07)
Figure E (Ler00 0001 08)
Figure F (Ler00 0001 09)
Figure G (Ler00 0001 10)
Figure H (Ler00 0001 11)
Figure I (Ler00 0001 12)
Figure J (Ler00 0001 13)
Figure K (Ler00 0001 14)
Figure L (Ler00 0001 15)
Figure M (Ler00 0001 16)
Figure N (Ler00 0001 17)
Figure O (Ler00 0001 18)
Figure P (Ler00 0001 19)
Figure Q (Ler00 0001 20)
Figure R (Ler00 0001 21)
Figure S (Ler00 0001 22)
Principal Display Panel – 300 mg/1.2 mL Carton Label (Ler00 0001 23)
This is a description of "LEROCHOL Injection" that contains important information such as storage instructions, dosage details (300 mg/1.2 mL), and administration method (subcutaneous injection). It emphasizes storing the product in the refrigerator within a specific temperature range (2°C to 8°C) and not freezing it. The text also mentions that the product can be kept at room temperature for a short period if necessary. Additionally, it states that the injection should be discarded after three months of removal from refrigeration or if kept at room temperature for five months. The product comes in a single-dose prefilled syringe and is sterile with no preservatives.*
Principal Display Panel – 300 mg/1.2 mL Tray Label (Ler00 0001 24)
This text provides information about Lerochol, an injection solution available in prefilled syringes with a concentration of 300 mg/1.2mL. It is intended for subcutaneous injection as a single dose and should be discarded if unused. The product contains inactive ingredients such as Histidine, polysorbate 80, and sodium chloride. The recommended dosage is to be determined based on Prescribing Information provided. It is advised to store Lerochol refrigerated at 36°F to 46°F (2°C to 8°C) in the original carton to protect it from light, avoiding freezing or shaking. The product details include the NDC number, manufacturer information, and batch details.*
Principal Display Panel – 300 mg/1.2 mL Prefilled Syringe Label (Ler00 0001 25)
This text contains information about a medication called LEROCHOL, which is an injection intended for subcutaneous administration. It is supplied in a single-dose prefilled syringe and should be discarded if any portion is unused. The medication is sterile and does not contain any preservatives. It is manufactured by LIB Therapeutics, Inc. in Cincinnati, OH. The specific lot number and expiration date are also provided.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
